➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 212887

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 212887 describes VOCABRIA, which is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the VOCABRIA profile page.

The generic ingredient in VOCABRIA is cabotegravir sodium. One supplier is listed for this compound. Additional details are available on the cabotegravir sodium profile page.
Summary for 212887
Applicant:Viiv Hlthcare
Ingredient:cabotegravir sodium
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 212887
Generic Entry Date for 212887*:
Constraining patent/regulatory exclusivity:

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 212887
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOCABRIA cabotegravir sodium TABLET;ORAL 212887 NDA ViiV Healthcare Company 49702-248 49702-248-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 30MG BASE
Approval Date:Jan 21, 2021TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 21, 2026
Regulatory Exclusivity Use:
Patent:  Get Started for $10Patent Expiration:Apr 28, 2026Product Flag?YSubstance Flag?YDelist Request?
Patent:  Get Started for $10Patent Expiration:Apr 28, 2026Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.